Next Article in Journal
Stereoselective Transformation of Cyclodecene-1,4-dione Systems, Derived from Steroids, to the Corresponding spiro-γ-lactones. A Semiempirical MO Study
Previous Article in Journal
The Need for Systematic Naming Software Tools for Exchange of Chemical Information
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Fluorescent 2,7-Dialkylamino-[1,8]-Naphthyridines: Preparation and Spectroscopic Properties

by
Christoph Hoock
1,*,
Jörg Reichert
2 and
M. Schmidtke
2
1
BYK-Gulden-Lomberg GmbH, D-78467 Konstanz, Germany
2
Institute for Virology, University of Jena, Winzerlaerstr. 10, D-07745 Jena, Germany
*
Author to whom correspondence should be addressed.
Molecules 1999, 4(10), 264-271; https://doi.org/10.3390/41000264
Submission received: 4 June 1999 / Accepted: 10 August 1999 / Published: 6 September 1999

Abstract

:
Substitution of 4-methyl-[1,8]-naphthyridine in 2 and 7 position by alkylamines leads to highly fluorescent compounds. The arrangement of hydrogen donor and acceptor groups of these naphthyridines allows interactions with guanine and guanine cytosine base pairs. The described synthesis offers easy access to these small and stable fluorescent probes.

Introduction

Fluorescent compounds are widely used as markers in biochemical and nucleic acid technologies and are the subject of intensive investigations. Many of the available markers, such as xanthene dyes, fulfil the necessary requirement for markers by having very high molar extinction and quantum yield. On the other hand, it is recognised that these compounds, due to the relatively large size, could interfere or even disturb the geometric structures under investigation. This may limit their use due to artefacts [1].
Coumarins [2], azacoumarins [3] and chinolones [4] are well known fluorescent dyes with a molecular shape and size similar to naphthyridines but differing in their capabilities to form hydrogen bonds. The dialkylamino substituted 4-methyl-[1.8] naphthyridines described here are new and stable compounds that can be obtained easily through a synthesis consisting of only a few steps, and show an interesting fluorescence behaviour. Their steric characteristics and ability to form hydrogen bonds are similar to donor substituted pyridopyrimidines [5] or purine bases such as guanine. The fluorescence of naphthyridines in the VIS region and thus their potential application as fluorescent markers, especially in molecular biology and related fields, has not been described previously. So they should be especially useful for fluorescent markers of nucleic acids [6].

Results and Discussion

Syntheses of 2.7-dialkylamino-4-methyl-[1.8]-naphthyridines

The synthesis of 2,7-di-(N-alkylamino)-substituted 4-methyl-[1,8]-naphthyridines (Scheme 1) can be accomplished by nucleophilic substitution of the 2,7-dichlor- or 7-acetamido-2-chlor-derivative of 4-methyl-[1,8]-naphthyridine with alkylamines. The synthesis of the starting materials 1 and 2 was carried out according to the method of Seide [7] and Petrow [8]. 2,7-Dichlor-4-methyl-[1,8]-naphthyridine 1 reacted with five different amines (Scheme 1). These highly fluorescent 4-methyl-2.7-dialkyamino-1.8-naphthyridines have not been described by others [9,10].
All reactions were carried out at elevated temperatures and pressure in the presence of equimolar quantities of copper powder. Except for methylamine which was prepared as a 30% (w/v) solution in methanol, all reactions were performed without additional solvent. Even at high temperature, liquid ammonia did not react with 2,7-dichlor-4-methyl-[1,8]-naphthyridin 1 to form a 2,7-diamino compound. In contrast to substitutions of the chlorine atoms at position 2 and 7 with sodium alkoxides [11], the complete substitution with amines needed vigorous conditions. In order to avoid monosubstitution, it was necessary to heat the reaction mixture for 12 to 18 h and to add copper powder in equimolar amounts. In our synthesis method, the method of Carboni and coworkers [12] was modified to yield cleaner products and to achieve shorter reaction times. Further shortening of the reaction times led to mixtures of the substitution products without preference for 2 or 7-substitution. Because of the donor effect of the nitrogen, the first substitution through an amine leads to decreased reactivity of the heterocyclus.
Using the above mentioned reaction we tried to obtain 2-N-alkylamino-7-amino-4-methyl-[1,8]-naphthyridines by reacting 7-acetamido-2-chlor-4-methyl-[1,8]-naphthyridin 2 with alkylamines. The products of these reactions however are identical to those of the reaction with 1. The yields and Rf values of the products are listed in table 1.
The double substitution of 2,7-dichlor-4-methyl-[1,8]-naphthyridin 1 and of 7-acetamido-2-chlor-4-methyl-[1,8]-naphthyridin 2 by alkylamines was proved by mass spectrometry, 1H-NMR-spectra and elemental analysis. Thus it could be shown, that under the reaction conditions described here, the chlorine as well as acetamide were substituted completely, monosubstitution was not observed.

Fluorescence and UV Behaviour

The dialkylamino-4-methyl-naphthyridines 3a-e are yellow to light green solids. A 1 x 10-3 M solution of these naphthyridines in methanol shows UV absorptions between 320 and 400 nm with excitation of n → π* transitions. This was proved by adding HMPT to the solutions of the naphthyridines in methanol. The enhanced polarity led to a blue shift of the n → π* transitions and a red shift of the π → π* transitions.
Diluted solutions show blue fluorescence even in daylight. Using an excitation wavelength of 340 nm a band without specific structure could be observed in the area between 360 – 500 nm. The fluorescence maxima are blue-shifted compared to 8-azacoumarins and 8-azaquinolones [13]. The fluorescence maximum of 3b in aqueous solutions (0.1 mM) can be shifted from 435 nm to 425 nm by adding DNA (1mg/l herring sperm [14]). The nature of the interaction between DNA and naphthyridines has not yet been determined.
The quantum yield of fluorescence Φ was determined using acridine orange as a standard [15] (Table 1). The quantum yields were not as high as those observed for classical fluorescence markers such as fluorescein, but the smaller size of the compounds described here and their ability to form hydrogen bonds can sometimes be more important than high quantum yields.

Biological use

Using fluorescence microscopy [16] we could show that 3a enters selectively the nucleus of MDCK-cells colouring the nucleoli (Fig. 1).
Staining with these naphthyridine leads to an intensive blue fluorescence of nuclei and nucleosomes when using UV or blue excitation light. Diffuse fluorescence signals were detected in the cytoplasm of 3a treated Madin Darby canine kidney (MDCK) cells. All other synthesised alkylamino substituted naphthyridines (3b-3e) enter the cell but remain in the cytoplasm and are concentrated in the nuclear membrane (Fig. 2). The fading of the fluorescence of 3b-3e at ambient temperature (quenching) seems to be caused by enzymatic processes in the cytoplasm.
Alkylamines and arylamines of [1,8]-naphthyridines show interesting biological properties [12]. The biological properties of these 4-methyl-2.7-dialkylamino-[1.8]-naphthyridines will be published elsewhere [17].
Even when these heterocycles are not stable in the cytoplasm for prolonged periods it is possible to use them as fluorescent probes of the cytoplasm and for staining experiments. Due to their easy access, high fluorescence quantum yield, and stability against irradiation and oxidation the 2,7-diaminosubstituted 4-methyl-[1,8]-naphthyridines are useful as fluorescent dyes for staining and marking experiments.

Experimental

General

Melting points were measured on a PHMK 80/2920 VEB Rapido and are uncorrected. UV/VIS spectra were measured on a Perkin Elmer spectrometer model LAMBDA 15 UV/VIS spectrometer. Fluorescence spectra and quantum yields were measured on a SLM AMINCO- model MHF 48000 spectrofluorometer (Urbana, Illinois, USA). NMR spectra were taken on a BRUKER AVANCE DRX 300 and DRX 500 spectrometer using TMS as a standard. J-values are given in Hz, shifts are given in ppm. Microanalyses were performed on a FOSS-HERAEUS CHNO rapid. Analytical thin layer chromatography was carried out using precoated Merck Kieselgel 60 and was visualised under UV at 346 nm. The solvent for TLC was a mixture of chloroform: methanol: HAc 10:1:0,5. Rf values and yields of 2,7-dialkyl-4-methyl-[1,8]naphthyridines are shown in table 1. All alkylamines were distilled prior to use.
The fluorescence investigations under in vitro conditions were performed in MDCK cells (provided by the Institute of Influenza viruses, Petersburg, Russia) as described previously [18]. The cells were propagated in Eagle´s minimal essential medium supplemented with 100 U/ml penicilline, 100 µg/ml streptomycine (SIGMA, Deisenhofen, Germany), and 10% fetal calf serum (PAA, Linz, Austria). Serial dilutions of naphthyridine derivatives were added to the supernatant of 48 h (37°, 5% CO2) preincubated 90% confluent MDCK monolayers. After further 24 h of incubation with either 3a or 3b at 37° with 5% CO2, the cells were fixed with methanol. The fluorescence label within the cells was visualized by fluorescence microscopy (Wild Leitz GmbH, Wetzlar, Germany) using an excitation wavelength of 355-425 nm.
General procedure for the generation of 2,7-dialkylaminosubstituted 4-methyl-[1,8]-naphthyridines 3a-e
2 g of the chloro compound [7] 1 or 2 and 50 mg copper powder and 50 ml of n-alkylamine were heated under pressure at 160 °C for 12 h with magnetic stirring. Except in the case of methylamine (30% w/v solution in methanol), no additional solvent was used.
After cooling, the alkyamine was removed under vacuum. The residue was diluted with water, acidified with diluted hydrochloric acid and filtered to remove unreacted starting material. The pH of the filtrate was adjusted to 8 using diluted ammonia and the product was then extracted with chloroform. The organic layer was dried with MgSO4, strongly concentrated (ca. 1-2 ml) and then precipitated by the addition of cold diethyl ether. The product was washed twice with cold diethyl ether ( 2 x 10 ml), dryed and finally purified by either recrystallisation from ethanol or by column chromatography over silica (chloroform-methanol (10:1)).

2,7-Dimethylamino-4-methyl-[1.8]-naphthyridine 3a

Yellow powder, mp 261°C (dec.) (Found: C, 65.8; H, 7.3; N, 26.0. Calc. for C11H14N4 (202.26) C, 65.3; H, 7.0; N, 26.2); δH (500 MHz, CDCl3) 2.41 (3 H, s, CH3-Naphth.), 3.04 (6 H, s, N-CH3), 6.15 (1H, s, H3), 6.30 (1 H, d, J 9.14, H6), 7.74 (1 H, d, J 9.14, H5); δC(75 MHz, CDCl3) 18.5 (Naphth-CH3), 28.8/28.9 (CH3), 110.7 (C3), 133.8 (C5), 134.9 (C6), 145.6 (C4), 157.1 (C9), 160.1/161.0 (C2/C7); MS (ESI+): Da/e (%) 203.1 (100) (M + H)+.

2,7-Dipropylamino-4-methyl-[1.8]-naphthyridine 3b

Light yellow powder, mp 242°C (dec.) (Found: C, 69.7; H, 8.6; N, 21.7 Calc. for C15H22N4 (258.37) C, 69.7; H, 8.8; N, 21.5); δH(300 MHz, CDCl3) 1.02 (6 H, t, J 7.31, 2x γ-CH3), 1.76 (4 H, m, J 7.31, 2x β-CH2), 2.44 (3 H, s, Naphth-CH3), 3.33 (4 H, br, 2x α-CH2), 6.18 (1 H, s, H3), 6.34 (1 H, d, J 7.77, H6), 7.71 (1 H, d, J 7.77, H5); δC(75 MHz, CDCl3) 11.5 (γ-CH3), 18.5 (Naphth-CH3), 22.4 (β-CH2), 44.4 (α-CH2), 103.1 (C3), 134.8 (C5), 136.8 (C6), 146.8 (C4), 162.3/162.7 (C2/C7); MS (EI+) m/z (%): 258 (76) (C15H22N4+), 243 (96) (C14H19N4+), 229 (100) (C13H17N4+), 216 (89) (C12 H16N4+), 201 (62) (C13H15N3+), (C11H13N4+), 188 (98) (C10H12N4+), 174 (50) (C9H10N4+), 158 (47) (C9H8N3+), MS (ESI+) Da/e (%): 259.5 (100) (M + H)+.

2,7-Dibutylamino-4-methyl-[1.8]-naphthyridine 3c

Yellow-green powder, mp 195°C (Found: C, 71.3; H, 9.2; N, 19.4 Calc. for C17H26N4 (286.42) C, 71.3; H, 9.1 N, 19.6; δH (300 MHz, DMSO-(D6)) 0.91 (6 H, t, J 7.31, δ-CH3), 1.37 (4 H, m, J 7.31, γ-CH2), 1.55 (4 H, m, J 7.31, β-CH2), 2.44 (3 H, s, Naphth-CH3), 3.40 (4 H, br, α-CH2), 6.59 (1 H, s, H3), 6.67 (1 H, d, J 9.14, H6), 7.95 (1 H, br, H5); δC(75 MHz, CDCl3) 13.8 (δ-CH2), 18.6 (Naphth-CH3), 20.3 (γ-CH2), 31.1 (β-CH2), 42.4 (α-CH2), 114.1 (C3), 135.0 (C5), 136.7 (C6), 148.6 (C4), 160.0 (C2/C7); MS (EI+) m/z (%): 286 (70) (C17H26N4+), 257 (100) (C15H21N4+), 243 (79) (C14H19N4+), 230 (74) (C13H19N4+), 215 (19) (C12H15N4+), 201 (45) (C11H13N4+), 188 (62) C10H12N4+), 174 (30), 158 (30), MS (ESI+) Da/e (%): 287 (100) (M + H)+,573 (11) (2M + H)+.

N2,N7-Bis-(2-methoxy-ethyl)-4-methyl-[1,8]naphthyridine-2,7-diamine 3d

Pale yellow powder, mp 104-106°C (Found: C, 62.1; H, 7.7 ; N, 19.3; Calc. for C15H22N4O2 (232.29) C, 62.1; H, 7.7; N, 19.1); δH (300 MHz, CDCl3) 2.42 (3 H, s, Naphth-CH3), 3.38 (6 H, s, 2x O-CH3), 3.60 (4 H, t, J 5.25, 2x CH2-O), 3.70 (4 H, t, J 5.02, 2x N-CH2), 6.26 (1 H, s, H3), 6.39 (1 H, d, J 8.91, H6), 7.76 (1 H, d, J 8.91, H5); δC(75 MHz, DMSO-(D6)) 17.6 (Naphth-CH3), 57.9 (O-CH3), 71.0 (CH2-O), 109.4 (C3), 132.7 (C5), 132.8 (C6), 143.8 (C4), 157.1 (C9), 158.8/158.9 (C2/C7); MS (EI+) m/z (%): 290 (53) (C15H22N4O2+), 275 (17) (C14H19N4O2+), 257 (36) (C14H17N4O+), 245 (74) (C13H17N4O+), 232 (100) (C12H18N4O+), 213 (68), 199 (19), 187 (62), 174 (25), MS (ESI+) Da/e (%): 291 (100) (M + H)+, 313 (25) (M + Na)+.

2,7-Dihexylamino-4-methyl-[1.8]-naphthyridine 3e

Yellow powder, mp 190°C (Found: C, 73.9; H, 9.8; N, 16.4 Calc. for C21H34N4 (342.53). C, 73.6; H, 10.0; N, 16.4; δH (500 MHz, CDCl3) 0.89 (6 H, t, J 6.31, 2x Hζ), 1.34 and 1.42 (12 H, m, J 6.31, 2x Hε−γ), 1.73 (4 H, m, J 7.41, Hβ) 2.43 (3 H, s, Naphth-CH3), 3.25 (4 H, t, J 7.09, N-CH3), 6.16 (1 H, s, H3), 6.32 (1 H, d, J 8.83, H6), 7.70 (1 H, d, J 8.83, H5); δC(125 MHz, CDCl3) 14.0 (CH2-ζ), 18.6 (Naphth-CH3), 22.6 (CH2-ε), 26.8 (CH2-γ), 29.0 (CH3-β), 31.6 (CH3-δ), 42.7 (N-CH2), 110.6 (C3), 133.6 (C5), 134.8 (C6), 145.5 (C4), 157.0 (C9), 159.2/159.4 (C2/C7); MS (EI+) m/z (%): 342 (11) (C21H34N4+), 313 (6) (C19H29N4+), 285 (15) (C17H25N4+), 271 (15), 259 (89), 243 (11), 230 (15), 202 (62) (C21H34N4+), 188 (100) (C10H12N4+), 175 (83), 159 (34) (C9H9N3+).

Acknowledgement

We gratefully acknowledge the support by Prof. Dr. R. Beckert Inst. of Organic Chemistry Jena and Prof. Dr. Stelzner of Institute of Virology Jena.

References and Notes

  1. a) Kricka, L.J. Nonisotopic DNA Probe Techniques; Acedemic Press: New York, 1992. [Google Scholar] ; b) Symons, R.H. Nucleic Acid Probes; CRC Press, 1989. [Google Scholar] ; c) Connolly, B.A.; Newman, P.C. Nucleic Acids Res. 1989, 17, 4957–4971.
  2. Drexhage, K.H.; Erikson, G.R.; Hawks, G.H.; Reynolds, G.A. Opt. Commun. 1975, 15, 399–403. b) Drexhage, K.H.; Reynolds, G.A. Opt. Commun. 1973, 13, 222–225. c) Drexhage, K.H. USP 3 873 940/1971.
  3. Fletcher, A.N. Appl. Phys. 1977, 14, 295–302.
  4. Hammond, P.R.; Atkins, R.L.; Henry, R.A.; Fletcher, A.N. USP 4 103 257/1976.
  5. Staubli, A.B.; Dervan, P.B. Nucleic Acids Res. 1994, 22, 2637–2642.
  6. Meier, T. Ph.D. Thesis, University of Konstanz Germany, 1995.
  7. Seide, O. Chem. Ber. 1926, 59, 2465–2473.
  8. Petrow, V.; Rewald, E.L.; Sturgeon, B. J. Chem. Soc. 1947, 1407–1411. [CrossRef]
  9. Mangini, A.; Colonna, M. Gazz. Chim. Ital. 1942, 72, 190–195.
  10. a) Bergstrom, F.W. J. Org. Chem. 1946, 11, 239–246. b) Wozniak, M.; Skiba, M. Pol. J. Chem. 1981, 55, 2429–2437.
  11. Ochiai, E.; Miyaki, K. Chem. Ber. 1941, 74, 1115–1126, ref. 9.
  12. Carboni, S.; Settimo, A.; Bertini, D.; Ferrarini, P.; Livi, O.; Tonetti, I. Il Farmaco 1975, 30, 185–196.
  13. Hammond, P.R.; Fletcher, A.N.; Henry, R.A.; Atkins, R.L. Appl. Phys. 1975, 8, 315–318.
  14. Obtained from Aldrich.
  15. Haugland, J. Handbook of Fluorescent Probes; Mol. Ed. Probes Inc.: Junction City, Oregon, 1986. [Google Scholar]
  16. Methods used for our experiments refer to Ploem, J.S. Fluorescence microscopy. In Light Microscopy – A Practical Approach; Lacey, A.J., Ed.; IRL Press: Oxford, 1989; p. 137, and references cited herein. [Google Scholar]
  17. Schmidtke, M.; Reichert, J.; Hoock, C. Unpublished work.
  18. Schmidtke, M.; Knorre, C.; Blei, L.; Stelzner, A.; Birch-Hirschfeld, E. Nucleosides, Nucleotides 1998, 17, 1557–1566.
  • Samples Availability: Samples available from the authors.
Scheme 1. Syntheses of 2,7-Di-(N-alkylamino)-4-methyl-[1,8]-naphthyridines.
Scheme 1. Syntheses of 2,7-Di-(N-alkylamino)-4-methyl-[1,8]-naphthyridines.
Molecules 04 00264 sch001
Figure 1. Fluorescence pattern in MDCK-cells after staining with 3a.
Figure 1. Fluorescence pattern in MDCK-cells after staining with 3a.
Molecules 04 00264 g001
Figure 2. Fluorescence pattern in MDCK-cells after staining with 3b.
Figure 2. Fluorescence pattern in MDCK-cells after staining with 3b.
Molecules 04 00264 g002
Table 1. Yield, Rf-Values and Quantum Yield of Fluorescence Φ.
Table 1. Yield, Rf-Values and Quantum Yield of Fluorescence Φ.
Nr.RYield [%]aRfΦ
12
3aCH3n. a.b340.200.25
3bn-C3H749180.460.19
3cn-C4H965220.550.28
3dn-C2H4-O-CH320220.260.24
3en-C6H136520.780.26
a Yields starting with 1 or 2 ;b not reacted with 1.

Share and Cite

MDPI and ACS Style

Hoock, C.; Reichert, J.; Schmidtke, M. Fluorescent 2,7-Dialkylamino-[1,8]-Naphthyridines: Preparation and Spectroscopic Properties. Molecules 1999, 4, 264-271. https://doi.org/10.3390/41000264

AMA Style

Hoock C, Reichert J, Schmidtke M. Fluorescent 2,7-Dialkylamino-[1,8]-Naphthyridines: Preparation and Spectroscopic Properties. Molecules. 1999; 4(10):264-271. https://doi.org/10.3390/41000264

Chicago/Turabian Style

Hoock, Christoph, Jörg Reichert, and M. Schmidtke. 1999. "Fluorescent 2,7-Dialkylamino-[1,8]-Naphthyridines: Preparation and Spectroscopic Properties" Molecules 4, no. 10: 264-271. https://doi.org/10.3390/41000264

Article Metrics

Back to TopTop